The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Yi-Ju Chan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Plastic and Reconstructive Surgery, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Vaccination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
This study aims to evaluate the effectiveness of anti‐severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccines in preventing the post‐acute sequelae of SARS‐CoV‐2 infection (PASC), commonly known as long COVID, and reducing all‐cause mortality among older patients. A retrospective cohort study was conducted using the TriNetX database. The study cohort consisted of older patients (age ≥ 65 years) with their first COVID‐19 illness between January 1, 2022, and May 31, 2024. Participants were divided into vaccinated and unvaccinated groups based on their vaccination status. Propensity score matching (PSM) was used to balance baseline characteristics. Cox regression models and log‐rank tests were applied to estimate the hazard ratio (HR) for PASC and all‐cause mortality during 30–180 days of follow‐up. The study included 189 059 geriatric patients who contracted SARS‐CoV‐2, with 5615 vaccinated and 183 444 unvaccinated. After PSM, each group contained 5615 patients. Vaccinated patients exhibited a significantly lower incidence of PASC symptoms (HR = 0.852, 95% CI: 0.778–0.933, p = 0.0005), particularly anxiety and depression, with a HR of 0.710 (95% CI: 0.575–0.878, p = 0.0015). Vaccination was also significantly associated with reduced all‐cause mortality (HR = 0.231, 95% CI: 0.136–0.394, p < 0.0001). The findings highlight the effectiveness of COVID‐19 vaccination in mitigating the development of PASC and decreasing mortality among older patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Plastic and Reconstructive Surgery, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Internal Medicine, Endocrinology and Metabolism, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
- Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- Division of Preventive Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Internal Medicine, Division of Nephrology, Chi Mei Medical Center, Tainan, Taiwan.
ORCID-Profile: Ya-Wen Tsai, Po-Yu Huang, Kuo-Chuan Hung, Chih-Cheng Lai, Jheng-Yan Wu
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Chan, Y. J., Chen, C. C., Tu, Y. K., Hsu, W. H., Tsai, Y. W., Liu, T. H., Huang, P. Y., Chuang, M. H., Hung, K. C., Lee, M. C., Yu, T., Lai, C. C., Weng, T. C., & Wu, J. Y. (2024). The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.70119
Vancouver
Chan YJ, Chen CC, Tu YK, Hsu WH, Tsai YW, Liu TH, et al. The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.70119
BibTeX
@article{Chan2024,
author = {Chan, Yi-Ju and Chen, Chia-Chen and Tu, Yu-Kuan and Hsu, Wan-Hsuan and Tsai, Ya-Wen and Liu, Ting-Hui and Huang, Po-Yu and Chuang, Min-Hsiang and Hung, Kuo-Chuan and Lee, Mei-Chuan and Yu, Tsung and Lai, Chih-Cheng and Weng, Tzu-Chieh and Wu, Jheng-Yan},
title = {The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.70119}
}
EUVIMED